“Buzz on the Street” Show: Cannabix Technologies (CSE: BLO) (OTC: BLOZF) License Agreement

Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) developer of the Cannabix Marijuana Breathalyzer is pleased to report that the Company has entered into an exclusive license agreement with the University of British Columbia (“UBC”) to use and commercialize certain technology for the detection of volatile organic compounds for testing (to be used for marijuana breathalyzer […]

The Latest “Buzz on the Street” Show: Featuring TruTrace Technologies (CSE: TTT) Blockchain Program

Shoppers Drug Mart announced a new initiative with software company, TruTrace Technologies (CSE: TTT) (OTC: BKKSF), to develop and deploy a blockchain-secured pilot program intended to increase transparency, interoperability and product identification within the medical cannabis industry (the “Pilot Program”). TruTrace Technologies has developed the first integrated blockchain platform to register and track intellectual property […]

The Latest “Buzz on the Street” Show: Featuring TruTrace Technologies (TSX-V: TTT) Advisor

TruTrace Technologies Inc. (TSX-V: TTT) (OTC: BKKSF) announced Deepak Anand, CEO and Co-Founder of Materia Ventures, will become an advisor to the Company. Mr. Anand brings significant experience having worked closely with senior government officials, politicians, policy makers, health professional organizations, clinical practitioners, educators and investors. Mr. Anand can provide business development leadership and direction, […]

The Latest “Buzz on the Street” Show: Featuring TruTrace Technologies Approval of CSE Listing

TruTrace Technologies Inc. (TSX-V: TTT) (OTC: BKKSF) (“TruTrace” or the “Company”), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, is pleased to announce that it has received conditional approval to list its common shares on the Canadian Securities Exchange (the “CSE”), and anticipates to voluntarily delist […]

The Latest “Buzz on the Street” Show: Featuring TruTrace Technologies (TSX-V: TTT) Letter of Intent

TruTrace Technologies Inc. (TSX-V: TTT) (OTC: BKKSF), creator of the first blockchain-enabled fully-integrated IP tracking platform for the cannabis industry, today announced it has entered into a letter of intent dated May 15, 2019 with Nonnie’s Nectar, LLC, a Los Angeles-based hemp extract company that produces premium full-spectrum hemp-based products grown in the U.S.A. using […]

The Latest “Buzz on the Street” Show: Featuring TruTrace Technologies (TSX-V: TTT) (OTC: BKKSF) News

TruTrace Technologies Inc. (TSX-V: TTT) (OTC: BKKSF) (“TruTrace” or the “Company”) today announced that it has entered into a letter of intent dated April 30, 2019 (the “LOI”) with Molecular Science Corp. (“MSC”). Under the terms of the LOI, the parties will work together to explore opportunities to combine the blockchain-secured technology of TruTrace with […]

“Buzz on the Street” Show: Featuring NutraLife Biosciences (OTCQB: NLBS) Coverage

NutraLife Biosciences, Inc. (OTCQB: NLBS) to launch a new line of Phytocannabinoid rich (PCR) water enhancing drops under its new in-house brand PCR Pure. NutraLife’s new CBD water enhancers will initially be available in four flavors: strawberry, grape, coconut and watermelon. Each 2 oz. bottle will contain 15 servings and have 20 mg per serving […]

Buzz on the Street Featuring Patriot One Technologies (TSX-V: PAT) (OTCQX: PTOTF)

Patriot One Technologies Inc. (TSX-V: PAT) (OTCQX: PTOTF) makers of the award-winning PATSCAN threat detection system today announced a partnership with defense contractor Raytheon Canada Limited (RCL), a subsidiary of Raytheon Company (NYSE: RTN) to extend developmental innovation of Patriot One’s threat detection technology and product pipeline. Patriot One has developed PATSCAN CMR™ the next […]

“Beehind the Buzz” Show: Featuring Q BioMed Inc. (OTCQB: QBIO) CEO Denis Corin

Q BioMed Inc. (OTCQB: QBIO) aims to accelerate the monetization of biomedical technologies through rapid innovation and collaborative partnerships with industry-leading researchers. Q BioMed believes its assets in oncology, vascular disease, and rare orphan diseases address unmet medical needs and large markets. Mr. Denis D. Corin is Chief Executive Officer and Chairman of the Board. […]